New patent expiration for Astellas drug MYCAMINE

00:06 EDT 16 Mar 2019 | BiotechBlog

Annual Drug Patent Expirations for MYCAMINE Mycamine is a drug marketed by Astellas and is included in one NDA. It is available from one supplier. There are two patents protecting…
The post New patent expiration for Astellas drug MYCAMINE appeared firs...

The post New patent expiration for Astellas drug MYCAMINE appeared first on Biotechblog.

Original Article: New patent expiration for Astellas drug MYCAMINE

More From BioPortfolio on "New patent expiration for Astellas drug MYCAMINE"